SLC6A3 and attention deficit-hyperactivity disorder: Methylphenidate prescribed for ADHD and bupropion used to treat depression, addiction, and seasonal affective disorder (SAD) also act as dopamine reuptake inhibitors (DRIs), a class of drugs that inhibit DAT activity [17].